Get all your news in one place.
100's of premium titles.
One app.
Start reading
Medical Daily
Medical Daily
Health
Cole Mercer

An Inhaled Drug Cut Lung Vessel Resistance 56 Percent More Than Placebo in a Midstage Trial

Numbers from a Trial That Has Not Yet Been Peer Reviewed

An experimental once daily inhaled drug sharply reduced resistance in the lung's blood vessels in a midstage trial of people with one of the harder forms of pulmonary hypertension to treat. Results were presented Sept. 8 at the European Respiratory Society International Congress in Basel, in a study of 135 adults.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.